JP2012509295A5 - - Google Patents

Download PDF

Info

Publication number
JP2012509295A5
JP2012509295A5 JP2011536843A JP2011536843A JP2012509295A5 JP 2012509295 A5 JP2012509295 A5 JP 2012509295A5 JP 2011536843 A JP2011536843 A JP 2011536843A JP 2011536843 A JP2011536843 A JP 2011536843A JP 2012509295 A5 JP2012509295 A5 JP 2012509295A5
Authority
JP
Japan
Prior art keywords
peptide
amyloid
seq
binds
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011536843A
Other languages
English (en)
Japanese (ja)
Other versions
JP6029280B2 (ja
JP2012509295A (ja
Filing date
Publication date
Priority claimed from DE102008037564A external-priority patent/DE102008037564A1/de
Application filed filed Critical
Publication of JP2012509295A publication Critical patent/JP2012509295A/ja
Publication of JP2012509295A5 publication Critical patent/JP2012509295A5/ja
Application granted granted Critical
Publication of JP6029280B2 publication Critical patent/JP6029280B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011536843A 2008-11-19 2009-11-17 D−ペプチドを有する抗−アミロイドβ−ペプチド抗体を製造するための組成物 Expired - Fee Related JP6029280B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102008037564A DE102008037564A1 (de) 2008-11-19 2008-11-19 Zusammensetzung zur Herstellung von anti-Amyloid beta-Peptid-Antikörpern mit D-Peptiden
DE102008037564.0 2008-11-19
PCT/EP2009/065308 WO2010057882A2 (de) 2008-11-19 2009-11-17 Zusammensetzung zur herstellung von anti-amyloid beta-peptid-antikörpern mit d-peptiden

Publications (3)

Publication Number Publication Date
JP2012509295A JP2012509295A (ja) 2012-04-19
JP2012509295A5 true JP2012509295A5 (enExample) 2013-01-17
JP6029280B2 JP6029280B2 (ja) 2016-11-24

Family

ID=41572521

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011536843A Expired - Fee Related JP6029280B2 (ja) 2008-11-19 2009-11-17 D−ペプチドを有する抗−アミロイドβ−ペプチド抗体を製造するための組成物

Country Status (6)

Country Link
US (1) US9051364B2 (enExample)
EP (1) EP2356144B1 (enExample)
JP (1) JP6029280B2 (enExample)
CN (1) CN102224168B (enExample)
DE (1) DE102008037564A1 (enExample)
WO (1) WO2010057882A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010017130B4 (de) * 2010-05-28 2018-11-29 Forschungszentrum Jülich GmbH Hybrid-Verbindung, deren Verwendung und Verfahren zu deren Herstellung
EP4052721A1 (en) 2011-06-24 2022-09-07 NoNO Inc. Combination therapy for ischemia
US9241970B2 (en) * 2011-12-13 2016-01-26 Nono Inc. Therapy for subarachnoid hemorrhage and ischemia
JP6434903B2 (ja) * 2012-04-05 2018-12-05 フォルシュングスツェントルム ユーリッヒ ゲゼルシャフト ミット ベシュレンクテル ハフツングForschungszentrum Juelich GmbH 多価アミロイドβに結合するD−ペプチド含有ポリマー及びその使用
DE102012108598A1 (de) * 2012-09-14 2014-04-10 Forschungszentrum Jülich GmbH Neue, von D3 abgeleitete D-enantiomere Peptide und deren Verwendung
ES2773125T3 (es) 2012-04-05 2020-07-09 Forschungszentrum Juelich Gmbh Procedimiento para el tratamiento de sangre, productos sanguíneos y órganos
DE102012102998B4 (de) * 2012-04-05 2013-12-05 Forschungszentrum Jülich GmbH Polymere, enthaltend multivalente Amyloid-Beta-bindende D-Peptide und deren Verwendung
DE102014003262A1 (de) 2014-03-12 2015-09-17 Forschungszentrum Jülich GmbH Amyloid-Beta-bindende Peptide und deren Verwendung für die Therapie und die Diagnose der Alzheimerschen Demenz
DE102013016002A1 (de) * 2013-09-26 2015-03-26 Forschungszentrum Jülich GmbH Zyklische, Amyloid-Beta-bindende Peptide und deren Verwendung
US10995118B2 (en) 2013-09-26 2021-05-04 Forschungszentrum Juelich Gmbh Amyloid-beta-binding peptides and the use thereof for the treatment and diagnosis of alzheimer's disease
DE102015003676A1 (de) * 2015-03-20 2016-09-22 Forschungszentrum Jülich GmbH Fachbereich Patente Spezifisch A-Beta Spezies bindende Peptide für die Therapie und/oder die Diagnose der Alzheimerschen Demenz
CA3070446A1 (en) 2017-07-25 2019-01-31 Immutics, Inc. Treating cancer by blocking the interaction of tim-3 and its ligand
CN120058944A (zh) 2019-01-30 2025-05-30 真和制药有限公司 抗gal3抗体及其用途
EP4157338A4 (en) 2020-05-26 2024-11-13 TrueBinding, Inc. METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING
TW202300517A (zh) 2021-03-12 2023-01-01 美商美國禮來大藥廠 抗類澱粉β抗體及其用途
WO2022251048A1 (en) 2021-05-24 2022-12-01 Eli Lilly And Company Anti-amyloid beta antibodies and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69333397T2 (de) * 1992-08-27 2004-12-09 Bioclones (Proprietary) Ltd., Sandton Retro-, inverso-, und retro-inverso synthetische peptidanaloge
US6277826B1 (en) * 1996-08-27 2001-08-21 Praecis Pharmaceuticals, Inc. Modulators of β-amyloid peptide aggregation comprising D-amino acids
DK1161449T3 (da) * 1999-03-04 2007-11-05 Praecis Pharm Inc Modulatorer af beta-amyloidpeptidaggregering, der omfatter d-aminosyrer
US6849714B1 (en) * 1999-05-17 2005-02-01 Conjuchem, Inc. Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
DE10117281A1 (de) * 2001-04-06 2002-10-24 Inst Molekulare Biotechnologie Peptid zur Diagnose und Therapie der Alzheimer-Demenz
US6906169B2 (en) 2001-05-25 2005-06-14 United Biomedical, Inc. Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
US20050026165A1 (en) * 2001-05-31 2005-02-03 Cindy Orser Detection of conformationally altered proteins and prions
TWI357414B (en) * 2003-12-17 2012-02-01 Wyeth Llc Aβ immunogenic peptide carrier conjugates and meth

Similar Documents

Publication Publication Date Title
JP2012509295A5 (enExample)
Flyak et al. Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2–MPER region
Sangesland et al. Allelic polymorphism controls autoreactivity and vaccine elicitation of human broadly neutralizing antibodies against influenza virus
JP2010514805A5 (enExample)
CN102224168B (zh) 用于生产抗淀粉状蛋白β肽抗体的含有D-肽的组合物
JP2011528561A5 (enExample)
JP2002528140A5 (enExample)
JP2009240315A5 (enExample)
JP2023525518A (ja) 新規アンキリンリピート結合タンパク質とその用途
RU2013106270A (ru) Моноклональное антитело против addl и его применения
JP2013542914A5 (enExample)
CN102498217A (zh) Hpv的e6蛋白的特异性抗体及其应用
Zhang et al. Multiple proteins of White spot syndrome virus involved in recognition of β-integrin
JP2005531286A (ja) HCVE2グリコプロテインに対して向けられ、invitro中和活性を有するヒトモノクローナル抗体Fab断片
JP2013505938A5 (enExample)
RU2022108606A (ru) Антитела к фактору ix padua
EP3992205A1 (en) Sars coronavirus-2 spike protein binding compounds
JP2012523221A5 (enExample)
CN103833830B (zh) 柯萨奇病毒a16型的保守中和表位多肽及其用途
JP2018529630A (ja) 自閉症を診断および治療するための抗原性ペプチドおよびその使用
CN114671947B (zh) 乙肝病毒不同亚型表面s蛋白高亲和力纳米抗体及其应用
AU2022239051A9 (en) Pharmaceutical composition for ameliorating acute lung injury and acute worsening of pulmonary fibrosis
JP2009525741A5 (ja) HERV−W干渉群に属するウィルスの包膜とhASCT受容体との間の相互作用に必要なペプチド領域からなるペプチド
RU2014102721A (ru) Способ получения агента, связывающегося с препро-вазопрессином или с его фрагментами
CN104277110A (zh) 一种针对人Tudor-SN蛋白T73位点的应激磷酸化抗体制备方法